{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:17:33Z","timestamp":1791811053019,"version":"4.3.4"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Lung function impairment, a hallmark of chronic airway diseases like chronic obstructive pulmonary disease (COPD), is often underdiagnosed in China. Preserved Ratio Impaired Spirometry (PRISm) may represent an early, subclinical stage of this process. However, a comprehensive understanding of their clinical phenotypes, effective predictive strategies for early identification in large populations, and the role of systemic inflammation remains underexplored, particularly in the Chinese context. This study aimed to describe the clinical phenotypes of lung function impairment, identify predictive factors using machine learning, and explore associated systemic inflammation in a large-scale population screening.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A prospective cross-sectional study was conducted in Hongtong County, China (2021\u20132024). Participants were classified into airflow obstruction, PRISm, and normal groups via portable spirometry. Using demographic, clinical, and laboratory data, we developed and validated several machine learning (ML) models to predict lung function impairment. Model performance was evaluated by the area under the receiver operating characteristic curve (AUC). Serum cytokines were measured by ELISA in matched sub-cohorts to assess systemic inflammation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among 9,284 enrolled adults, 51.0% had airflow obstruction, 6.7% had PRISm, and 42.3% were normal. We identified distinct phenotypes: the PRISm group was predominantly female with lower smoking rates but a higher risk of coronary heart disease. The airflow obstruction group was characterized by classical risk factors (older age, male sex, lower BMI, smoking) and specific renal and cerebrovascular comorbidities. The ML models identified older age, male sex, lower BMI, respiratory symptoms (cough, dyspnea), and higher creatinine and hemoglobin as key predictors, demonstrating modest performance with an AUC of 0.635 in the validation set. Immunologically, individuals with airflow obstruction or PRISm showed significantly lower serum IL-2 and higher IL-5 and IL-17A levels compared to controls.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In a large-scale screening, individuals with airflow obstruction and PRISm present with distinct clinical phenotypes. A predictive model using simple clinical variables can help identify individuals at higher risk for lung function impairment, despite modest performance. Serum IL-2, IL-5, and IL-17A are potential biomarkers for the early recognition and understanding of airflow limitation.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1657151","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T04:12:56Z","timestamp":1758168776000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Relationship between lung function impairment, clinical characteristics and systemic inflammation based on a large-scale population screening"],"prefix":"10.3389","volume":"12","author":[{"given":"Xiaojun","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxia","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuming","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhancheng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengtong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianyu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,18]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12931-024-03051-2","article-title":"Global, regional, and national burden of chronic obstructive pulmonary disease and its attributable risk factors from 1990 to 2021: an analysis for the Global Burden of Disease Study 2021","volume":"26","author":"Wang","year":"2025","journal-title":"Respir Res."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1007\/s12325-024-02855-4","article-title":"Implications of cardiopulmonary risk for the management of COPD: a narrative review","volume":"41","author":"Singh","year":"2024","journal-title":"Adv Ther"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/S0140-6736(18)30841-9","article-title":"Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study","volume":"391","author":"Wang","year":"2018","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3978\/j.issn.2072-1439.2013.08.04","article-title":"Chronic obstructive pulmonary disease in China: the potential role of indacaterol","volume":"5","author":"Gao","year":"2013","journal-title":"J Thorac Dis."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1038\/s41598-023-29922-0","article-title":"Preserved ratio impaired spirometry with or without restrictive spirometric abnormality","volume":"13","author":"Miura","year":"2023","journal-title":"Sci Rep"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2147\/COPD.S506115","article-title":"Associated Factors and Pulmonary Function Outcomes of Preserved Ratio Impaired Spirometry: A Scoping Review","volume":"20","author":"Zhang","year":"2025","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13643-024-02549-6","article-title":"Association of preserved ratio impaired spirometry with mortality and cardiovascular diseases: a systematic review and meta-analysis","volume":"13","author":"Li","year":"2024","journal-title":"Syst Rev."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"753","DOI":"10.2147\/COPD.S453086","article-title":"Preserved Ratio Impaired Spirometry (PRISm): A Global Epidemiological Overview, Radiographic Characteristics, Comorbid Associations, and Differentiation from Chronic Obstructive Pulmonary Disease","volume":"19","author":"Huang","year":"2024","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.3760\/cma.j.cn112147-20220518-00426","article-title":"Progress in preserved ratio impaired spirometry","volume":"45","author":"Zhao","year":"2022","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"8166","DOI":"10.1038\/s41598-025-90381-w","article-title":"Associations between life's essential 8 and preserved ratio impaired spirometry","volume":"15","author":"Lai","year":"2025","journal-title":"Sci Rep"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"10447","DOI":"10.1038\/s41598-025-93359-w","article-title":"Nomogram to predict progression from preserved ratio impaired spirometry to chronic obstructive pulmonary disease","volume":"15","author":"Wu","year":"2025","journal-title":"Sci Rep"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12931-024-02841-y","article-title":"The prevalence and mortality risks of PRISm and COPD in the United States from NHANES 2007-2012","volume":"25","author":"Cadham","year":"2024","journal-title":"Respir Res"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"230135","DOI":"10.1183\/16000617.0135-2023","article-title":"Association of preserved ratio impaired spirometry with mortality: a systematic review and meta-analysis","volume":"32","author":"Yang","year":"2023","journal-title":"Eur Respir Rev"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3390\/arm92020018","article-title":"How to enhance the diagnosis of early stages of chronic obstructive pulmonary disease (COPD)? The role of Mobile spirometry in COPD screening and diagnosis-a systematic review","volume":"92","author":"Jankowski","year":"2024","journal-title":"Adv Respir Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12931-014-0089-y","article-title":"Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene","volume":"15","author":"Wan","year":"2014","journal-title":"Respir Res."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1111\/risa.12165","article-title":"A tiered framework for risk-relevant characterization and ranking of chemical exposures: applications to the National Children's study (NCS)","volume":"34","author":"Georgopoulos","year":"2014","journal-title":"Risk Anal"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ncl.2010.12.004","article-title":"Demographic, genetic, and environmental factors that modify disease course","volume":"29","author":"Marrie","year":"2011","journal-title":"Neurol Clin"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"5224","DOI":"10.3390\/s24165224","article-title":"Sea horse optimization-deep neural network: a medication adherence monitoring system based on hand gesture recognition","volume":"24","author":"Amirthalingam","year":"2024","journal-title":"Sensors (Basel)"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1497307","DOI":"10.3389\/frai.2024.1497307","article-title":"A bird's-eye view of the biological mechanism and machine learning prediction approaches for cell-penetrating peptides","volume":"7","author":"Ramasundaram","year":"2024","journal-title":"Front Artif Intell"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1385\/IR:36:1:175","article-title":"Pneumocystis colonization, airway inflammation, and pulmonary function decline in acquired immunodeficiency syndrome","volume":"36","author":"Norris","year":"2006","journal-title":"Immunol Res"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2147\/COPD.S152291","article-title":"Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease","volume":"13","author":"Tashkin","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/medsci12020018","article-title":"Analysis of endocrine and inflammatory markers in preserved ratio impaired spirometry","volume":"12","author":"Jesus","year":"2024","journal-title":"Med Sci (Basel)"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2300806","DOI":"10.1183\/13993003.00806-2023","article-title":"From pre-COPD to COPD: a simple, low cost and easy to IMplement (SLIM) risk calculator","volume":"62","author":"Divo","year":"2023","journal-title":"Eur Respir J"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"16000","DOI":"10.1038\/s41598-025-94399-y","article-title":"Development and validation a nomogram to predict long-term mortality risks of PRISm and mild-to-moderate COPD based on NHANES 2007-2012","volume":"15","author":"Hou","year":"2025","journal-title":"Sci Rep"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1121900","DOI":"10.3389\/fendo.2023.1121900","article-title":"Circulating liver function markers and the risk of COPD in the UK biobank","volume":"14","author":"Du","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1183\/09031936.03.00405703","article-title":"Systemic effects of chronic obstructive pulmonary disease","volume":"21","author":"Agust\u00ed","year":"2003","journal-title":"Eur Respir J"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"417","DOI":"10.26444\/aaem\/83413","article-title":"IgE-dependent sensitization in patients with COPD","volume":"25","author":"Bo\u017cek","year":"2018","journal-title":"Ann Agric Environ Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1800174","DOI":"10.1183\/13993003.00174-2018","article-title":"IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis","volume":"54","author":"Starkey","year":"2019","journal-title":"Eur Respir J"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.2147\/COPD.S131877","article-title":"Serum IL-1\u03b2 and IL-17 levels in patients with COPD: associations with clinical parameters","volume":"12","author":"Zou","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1164\/rccm.202308-1452OC","article-title":"Susceptible young adults and development of chronic obstructive pulmonary disease later in life","volume":"210","author":"\u00c7olak","year":"2024","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1657151\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T04:12:58Z","timestamp":1758168778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1657151\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,18]]},"references-count":30,"alternative-id":["10.3389\/fmed.2025.1657151"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1657151","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,18]]},"article-number":"1657151"}}